(Q78881220)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12565983%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

title

Phase II study of LU 103793 (dolastatin analogue) in patients with metastatic breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12565983%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

main subject

metastatic breast cancer

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12565983%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

author name string

P Kerbrat

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12565983%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

V Dieras

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12565983%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

N Pavlidis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12565983%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

J Wanders

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12565983%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

P Fumoleau

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12565983%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

EORTC Early Clinical Studies Group/New Drug Development Office

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12565983%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

publication date

1 February 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12565983%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

17 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12565983%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12565983%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12565983%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

page(s)

317-320

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12565983%20AND%20SRC:MED&resulttype=core&format=json

Marine organisms as a source of new anticancer agents

17 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900531-2

7 January 2021

Dolastatin 15, a potent antimitotic depsipeptide derived from Dolabella auricularia. Interaction with tubulin and effects of cellular microtubules

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900531-2

7 January 2021

Phase I and pharmacokinetic study of the water-soluble dolastatin 15 analog LU103793 in patients with advanced solid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900531-2

7 January 2021

Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900531-2

7 January 2021

Activity of the dolastatin analogue, LU103793, in malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900531-2

7 January 2021

10.1016/S0959-8049(02)00531-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12565983%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

1 reference